What to Know:
- Key dates for potential XRP ETF approvals are concentrated in the second half of November.
- Approval would legitimize XRP, making it more accessible to portfolio managers and deepening liquidity.
- Institutional demand could shift price discovery toward allocation cycles rather than speculative bursts.
The approval cycle for a spot XRP ETF has entered a crucial phase, with several issuers slated for review this November. This period could be transformative for XRP, potentially opening the doors to significant institutional investment. The concentration of review dates suggests that the market will soon gain clarity on the future of XRP ETFs.
Important dates to watch include reviews for Bitwise, Franklin Templeton, 21Shares, CoinShares, Grayscale, and WisdomTree throughout November. The interest from Wall Street is evident, with discussions pointing to a potential $1.5 trillion in managed institutional capital that could be directed toward XRP-related products. Even a small allocation from these firms could significantly impact the asset.

ETF approval would legitimize XRP in a similar way to Bitcoin ETFs, making it allocation-ready and compliance-screened. It would also grant access to portfolio managers who previously faced mandate limitations. A significant increase in liquidity is also anticipated, further stabilizing the digital asset.
Currently, XRP’s price structure faces challenges from declining moving averages and a broader corrective trend. However, a regulated inflow structure could alter this dynamic, shifting price discovery toward more mechanical allocation cycles. The network fundamentals of XRP appear stable, with payment volume recently exceeding one billion.
The market’s perception could shift dramatically with early approval from a major issuer. Given the near-consecutive nature of these reviews, November could mark a turning point for XRP, finally encountering genuine institutional demand.
Source: Original article


